Valley Brook Capital Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$942K Buy
2,645
+45
+2% +$14.5K 0.53% 47
2026
Q2
$1.26M Buy
2,600
+275
+12% +$73K 0.71% 40
2026
Q1
$255K Buy
2,325
+75
+3% +$10.7K 0.17% 98
2025
Q4
$374K Buy
2,250
+780
+53% +$130K 0.25% 80
2025
Q3
$288K Buy
+1,470
New +$242K 0.19% 92

Other funds holding ALAB

Valley Brook Capital Group's ALAB Position: Q3 2026 in Review

Valley Brook Capital Group increased its Astera Labs (ALAB) stake by 1.7% in Q3 2026, buying an estimated $14.5K and bringing the position to 2,645 shares worth $942K. The position accounts for 0.53% of the portfolio, ranked #47.

Valley Brook Capital Group first reported a position in ALAB in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.26M in Q2 2026. 804 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Valley Brook Capital Group held 2,645 shares of Astera Labs worth $942K as of Q3 2026.
  • Valley Brook Capital Group bought 45 Astera Labs shares in Q3 2026, an estimated $14.5K.
  • Astera Labs made up 0.53% of Valley Brook Capital Group's portfolio in Q3 2026, its #47 holding.
  • Valley Brook Capital Group first reported a position in Astera Labs in Q3 2025 and has held it in 5 quarters since.
  • Valley Brook Capital Group's Astera Labs position peaked at $1.26M in Q2 2026.
  • 804 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Valley Brook Capital Group's 13F filing for Q3 2026, filed 26 Oct 2026.